Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Detection, prevention and treatment of gut microbiome dysbiosis

4.8

Accredited (Credits: 1)
Free
1h 14min

Synopsis

Alterations in the gut microbiome may be implicated in the pathogenesis of several non-communicable diseases and in the transition of these conditions to chronicity. Many studies have shown links between faecal microbiota composition and disease, including metabolic, inflammatory and neoplastic disorders. However, the exact (if any) causative role that microbiota changes may have in those diseases remains unclear. Thus, there has been little translation of microbiome science into clinical practice so far, especially in the domains of diagnosis and prognosis, due to the lack of supportive evidence for test and treat strategies. Nevertheless, it is becoming clear that developing and maintaining gut microbiota diversity is a novel clinical target for health promotion and disease prevention, and that diet and probiotics are the natural and most efficient way to improve diversity. This activity is supported by an independent support grant from Biocodex Microbiota Institute.

Objectives

  • 1. Recognize dysbiosis and its relationship with the gut microbiota.
  • 2. Discuss how gut microbiome dysbiosis can be detected, prevented and treated clinically.

Accreditation

This course is accredited with 1 ECMEC credit valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

1h 14min

Target audience

Gastroenterology, Endocrinology, Family medicine, General practice, Internal medicine, Addiction medicine, Adolescent medicine, Aerospace medicine, Allergy, Immunology, Anesthesiology, Cardiology, Cardiothoracic surgery, Clinical neurophysiology, Colorectal surgery, Dermatology, Emergency medicine, Forensic pathology, Forensic psychiatry, General surgery, General surgical oncology, Geriatrics, Gynecologic oncology, Hematology, Infectious disease, Intensive care medicine, Interventional radiology, Medical biochemistry, Medical genetics, Medical oncology, Neonatology, Nephrology, Neurology, Neuropathology, Neuroradiology, Neurosurgery, Nuclear medicine, Obstetrics, Gynecology, Occupational medicine, Ophthalmology, Oral, Maxillofacial surgery, Orthopedic surgery, Otology neurotology, Otorhinolaryngology, Pain medicine, Palliative care, Pathology, Pediatric surgery, Pediatrics, Physical, Rehabilitation, Plastic, Aesthetic surgery, Preventive medicine, Psychiatry, Public health, Radiation oncology, Radiology, Reproductive, Infertility, Respiratory medicine, Rheumatology, Sports medicine, Thoracic surgery, Urology, Vascular surgery, Other

Authors

Prof Dr Francisco Guarner

Francisco Guarner, MD, PhD. has a degree in Medicine and Surgery and specialized in Digestive Diseases. He carries out his professional activity in the Digestive Pathology Service of the Universitari Vall d'Hebró Hospital. He has been a research fellow at the Liver United at Kings College Hospital in London and a research fellow in the Prostaglandin Research department of Welcome Research Laboratories. He is currently a member of the Centre of Network Biomedical Research of hepatic and digestive diseases as principal investigator of the inflammatory bowel diseases group and a member of the Board of Directors of the International Scientific Association for Probiotics and Prebiotics. He is also president of the Board of Directors of the Probiotics and Prebiotics Spanish Society, member of the Guidelines & Publications Committee of WGO-OMGE (World Gastroenterology Organization) and member of the Steering Committee of the International Human Microbiome Consortium (IHMC).

Conflicts of interests statement:

Dr. Francisco Guarner receives grants or research supports from Abbvie, Takeda and AB-Biotics, and receives honoraria or consultation fees from Danone, Biocodex, Sanofi, Actial and Menarini but reports having no potential conflicts of interest on the topic of this course. All of the relevant financial relationships of this individual for this activity have been mitigated.

Testimonials

Read more reviews onTrustpilot

FAQs